Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: Insights from a high-volume single-center registry

Journal of Invasive Cardiology

Volumn 23, Issue 8, 2011, Pages 328-333

  Pedersen, Sune ^a   Galatius, Soren ^a   Mogelvang, Rasmus ^c   Abildstrom, Steen Z ^b   Sorensen, Rikke ^a   Galloe, Anders ^a   Abildgaard, Ulrik ^a   Hansen, Peter ^a   Davidsen, Ulla ^a   Iversen, Allan ^a   Bech, Jan ^a   Madsen, Jan K ^a   Jensen, Jan S ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c HOLBÆK HOSPITAL   (Denmark)

Author keywords

bare metal stent; drug eluting stent; primary percutaneous coronary intervention; ST segment elevation myocardial infarction; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIAC PATIENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY THROMBOSIS; DENMARK; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 80052010931     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-742. (Pubitemid 37010777)
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
3. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104. (Pubitemid 36109551)
4. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;51:210-247.
5. Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction: A comprehensive review of contemporary management options. J Am Coll Cardiol 2007;50:917-929. (Pubitemid 47313604)
6. Nallamothu BK, Wang Y, Magid DJ, et al. Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis. Circulation 2006;113:222-229.
7. Spaulding C, Morice MC, Lancelin B, et al. Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. Eur Heart J 2006;27:1054-1060.
8. Iijima R, Mehilli J, Schömig A, Kastrati A. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents. Minerva Cardioangiol 2006;54:539-555. (Pubitemid 44702085)
9. Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004;364:583-591. (Pubitemid 39094175)
10. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-1039. (Pubitemid 46376803)
11. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019. (Pubitemid 46376801)
12. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004;109:701-705. (Pubitemid 38222887)
13. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
14. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011. (Pubitemid 33027038)
15. Guagliumi G, Farb A, Musumeci G, et al. Images in cardiovascular medicine. Sirolimuseluting stent implanted in human coronary artery for 16 months: Pathological findings. Circulation 2003;107:1340-1341. (Pubitemid 36314421)
16. Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: The importance of thrombus burden. J Am Coll Cardiol 2007;50:573-583. (Pubitemid 47198999)
17. Gonzalo N, Barlis P, Serruys PW, et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: Insights from optical coherence tomography. J Am Coll Cardiol Interv 2009;2:445-452.
18. Kukreja N, Onuma Y, Garcia-Garcia HM, et al. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. J Am Coll Cardiol Interv 2009;2:534-541.
19. Leibundgut G, Nietlispach F, Pittl U, et al. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina-Comparison of the effects of drug-eluting versus bare-metal stents. Am Heart J 2009;158:271-276.
20. van der Hoeven BL, Liem SS, Dijkstra J, et al. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: Acute and 9-month intravascular ultrasound results of the MISSION! Intervention study. J Am Coll Cardiol Interv 2008;1:192-201. (Pubitemid 351506561)
21. Maehara A, Mintz GS, Lansky AJ, et al. Volumetric intravascular ultrasound analysis of paclitaxel-eluting and bare-metal stents in acute myocardial infarction. The harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy. Circulation 2009;120:1875-1882.
22. Cutlip DE, Windecker S, Mehran R, et al. Clinical endpoints in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351. (Pubitemid 46685903)
23. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-448. (Pubitemid 27382061)
24. Madsen M, Davidsen M, Rasmussen S, et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003;56:124-130. (Pubitemid 36315938)
25. Hordijk-Trion M, Lenzen M, Wijns W, et al. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: Results from the Euro heart survey on coronary revascularization. Eur Heart J 2006;27:671-678.
26. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
27. Kukreja N, Onuma Y, Garcia-Garcia HM, et al. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2009;2:534-541.
28. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591. (Pubitemid 44881238)
29. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667-678. (Pubitemid 46281313)
30. Brar SS, Leon MB, Stone GW, et al. Use of drug-eluting stents in acute myocardial infarction: A systematic review and meta-analysis. J Am Coll Cardiol 2009;53:1677-1689.
31. Steg PG, Fox KA, Eagle KA, et al. Mortality following placement of drug-eluting and baremetal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009;30:321-329.
32. Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359:1330-1342.
33. Shishehbor MH, Amini R, Oliveria LP, et al. Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2008;1:227-232. (Pubitemid 351804182)
34. Brodie BR, Stuckey T, Downey W, et al. Outcomes with drug-eluting stents versus bare-metal stents in acute ST-elevation myocardial infarction: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Catheter Cardiovasc Interv 2008;72:893-900.
35. Jensen LO, Maeng M, Thayssen P, et al. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Intervent 2008;1:176-184.
36. Carlsson J, James SK, Lindback J, et al. Outcome of drug-eluting versus bare-metal stenting used according to on-and off-label criteria. J Am Coll Cardiol 2009;53:1389-1398.
37. Di LE, Sauro R, Varricchio A, et al. Long-term outcome of drug-eluting stents compared with bare-metal stents in ST-segment elevation myocardial infarction: Results of the paclitaxel-or sirolimus-eluting stent versus bare metal stent in primary angioplasty (PASEO) randomized trial. Circulation 2009;120:964-972.
38. Vink MA, Dirksen MT, Suttorp MJ, et al. Five-year follow-up after primary PCI with a paclitaxal-eluting stent versus a bare-metal stent in acute ST-elevation myocardial infarction. ACC/i2 2010 Late-breaking clinical trial session, 2010 March 16.
39. Clemmensen P, Kelbaek H, Kaltoft A, et al. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction. 3-year follow-up of the randomized DEDICATION trial. ACC/i2 2010 Late-breaking clinical trial session, 2010 March 16.